CNTB Competitors & Alternatives

Compare Connect Biopharma Holdings Ltd with similar stocks in the same industry

Biotechnology

CNTB

Main Stock
$0.61
-5.07%
Tradestie Score
40
Market Cap
$83.60M
Revenue Growth
56.7%
Analyst Upside
+883.0%

Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)

Bottleneck Score: 2/10 Drug Discovery Biotech Drug Design
Competitive Moat: None
Core Technology Stack: Monoclonal antibodies, Small-molecule modulators, Targeted immunotherapy
Major Customers 3
Future pharma partners Specialty clinics Patients with atopic dermatitis/asthma/IBD
Critical Suppliers 3
CROs for clinical trials Biologics CMOs API manufacturers
Direct Ecosystem Rivals 3

Top Competitors

220 stocks in Biotechnology
Company Price Market Cap P/E Score Action
CLYM Climb Bio, Inc. Common Stock
$9.63
-3.12%
$133.50M - 45 Compare
SRZN Surrozen, Inc. Common
$30.16
-6.68%
$117.07M - 33 Compare
ANRO Alto Neuroscience Inc.
$25.11
-7.41%
$110.20M - 34 Compare
ADAG Adagene Inc. American Depositary Shares
$1.56
-2.50%
$94.26M - 38 Compare
ENTX Entera Bio Ltd. Ordinary Shares
$3.03
+0.17%
$84.52M - 53 Compare
UNCY Unicycive Therapeutics, Inc. Common Stock
$3.73
+0.68%
$78.68M - 42 Compare
ALGS Aligos Therapeutics, Inc. Common Stock
$1.41
-15.06%
$71.53M - 38 Compare
IMMX Immix Biopharma, Inc. Common Stock
$7.20
-3.74%
$67.94M - 52 Compare
INAB IN8bio, Inc. Common Stock
$0.86
+5.47%
$10.26M - 52 Compare
DRMA Dermata Therapeutics, Inc. Common Stock
$0.58
-3.14%
$3.50M - 42 Compare

Data updated: Nov 17, 2026 | Industry: Biotechnology (SIC 2834)

220 stocks in this industry